540 related articles for article (PubMed ID: 18077068)
1. Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with anti-ribosomal P antibodies.
Nery FG; Borba EF; Viana VS; Hatch JP; Soares JC; Bonfá E; Neto FL
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):695-700. PubMed ID: 18077068
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and clinical significance of anti-ribosomal P antibody in childhood-onset systemic lupus erythematosus.
Aldar H; Lapa AT; Bellini B; Sinicato NA; Postal M; Fernandes PT; Costallat LT; Marini R; Appenzeller S
Lupus; 2012 Oct; 21(11):1225-31. PubMed ID: 22740428
[TBL] [Abstract][Full Text] [Related]
3. Common mental disorders and psychological distress in systemic lupus erythematosus are not associated with disease activity.
Jarpa E; Babul M; Calderón J; González M; Martínez ME; Bravo-Zehnder M; Henríquez C; Jacobelli S; González A; Massardo L
Lupus; 2011 Jan; 20(1):58-66. PubMed ID: 21078764
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease.
Reichlin M; Broyles TF; Hubscher O; James J; Lehman TA; Palermo R; Stafford HA; Taylor-Albert E; Wolfson-Reichlin M
Arthritis Rheum; 1999 Jan; 42(1):69-75. PubMed ID: 9920016
[TBL] [Abstract][Full Text] [Related]
5. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
[TBL] [Abstract][Full Text] [Related]
6. Anti-ribosomal-P antibodies in lupus patients and healthy controls: evaluation of three ELISA assays.
Agmon-Levin N; Gilburd B; Kivity S; Katz BS; Flitman-Katzevman I; Shoenfeld N; Paran D; Langevitz P; Shoenfeld Y
Isr Med Assoc J; 2009 Jul; 11(7):403-6. PubMed ID: 19911490
[TBL] [Abstract][Full Text] [Related]
7. Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus.
Haddouk S; Marzouk S; Jallouli M; Fourati H; Frigui M; Hmida YB; Koubaa F; Sellami W; Baklouti S; Hachicha J; Bahloul Z; Masmoudi H
Rheumatology (Oxford); 2009 Aug; 48(8):953-7. PubMed ID: 19502474
[TBL] [Abstract][Full Text] [Related]
8. Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.
Hirohata S; Arinuma Y; Takayama M; Yoshio T
Arthritis Res Ther; 2007; 9(3):R44. PubMed ID: 17472755
[TBL] [Abstract][Full Text] [Related]
9. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus.
Tomietto P; Annese V; D'agostini S; Venturini P; La Torre G; De Vita S; Ferraccioli GF
Arthritis Rheum; 2007 Dec; 57(8):1461-72. PubMed ID: 18050188
[TBL] [Abstract][Full Text] [Related]
10. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
Yoshio T; Hirata D; Onda K; Nara H; Minota S
J Rheumatol; 2005 Jan; 32(1):34-9. PubMed ID: 15630721
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.
Mok CC; Lau CS; Wong RW
J Rheumatol; 2001 Apr; 28(4):766-71. PubMed ID: 11327248
[TBL] [Abstract][Full Text] [Related]
12. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
[TBL] [Abstract][Full Text] [Related]
13. Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies.
Conti F; Alessandri C; Bompane D; Bombardieri M; Spinelli FR; Rusconi AC; Valesini G
Arthritis Res Ther; 2004; 6(4):R366-72. PubMed ID: 15225372
[TBL] [Abstract][Full Text] [Related]
14. [Psychiatric manifestations in patients with erythematosus systemic lupus].
Rubio Valladolid G; Olivares Zarco D; Orengo F; Carrasco SD
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1994; 22(4):158-63. PubMed ID: 7810371
[TBL] [Abstract][Full Text] [Related]
15. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus.
Isshi K; Hirohata S
Arthritis Rheum; 1998 Oct; 41(10):1819-27. PubMed ID: 9778223
[TBL] [Abstract][Full Text] [Related]
16. Clinical and serologic factors associated with lupus pleuritis.
Mittoo S; Gelber AC; Hitchon CA; Silverman ED; Pope JE; Fortin PR; Pineau C; Smith CD; Arbillaga H; Gladman DD; Urowitz MB; Zummer M; Clarke AE; Bernatsky S; Hudson M; Tucker LB; Petty RE; ; Peschken CA
J Rheumatol; 2010 Apr; 37(4):747-53. PubMed ID: 20110526
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
Husebye ES; Sthoeger ZM; Dayan M; Zinger H; Elbirt D; Levite M; Mozes E
Ann Rheum Dis; 2005 Aug; 64(8):1210-3. PubMed ID: 15708887
[TBL] [Abstract][Full Text] [Related]
18. Somatic and psychological features of headache in systemic lupus erythematosus.
Omdal R; Waterloo K; Koldingsnes W; Husby G; Mellgren SI
J Rheumatol; 2001 Apr; 28(4):772-9. PubMed ID: 11327249
[TBL] [Abstract][Full Text] [Related]
19. VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype.
Bhat NM; Lee LM; van Vollenhoven RF; Teng NN; Bieber MM
J Rheumatol; 2002 Oct; 29(10):2114-21. PubMed ID: 12375320
[TBL] [Abstract][Full Text] [Related]
20. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
